目錄:MedChemExpress LLC>>生化試劑>> Tauro-β-muricholic acid sodium | MCE
CAS | 145022-92-0 | 分子量 | 537.68 |
---|---|---|---|
分子式 | C??H??NNaO?S | 供貨周期 | 現(xiàn)貨 |
貨號 | HY-135103 | 應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥 |
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報,我們不為任何個人用途提供產(chǎn)品和服務(wù)。
CAS No. : 145022-92-0
產(chǎn)品活性:Tauro-β-muricholic Acid sodium (T-βMCA sodium), a endogenous metabolite, is a competitive and reversible farnesoid X receptor (FXR) antagonist, with an IC50 of 40 μM.
研究領(lǐng)域:Metabolic Enzyme/Protease
作用靶點:FXR
In Vitro: T-βMCA sodium inhibits FXR reporter activity in the CRC cell line HT29 (EC50 ~10 μM).
T-βMCA sodium dose-dependently increases WNT signaling in HT29 and HCT116 cells.
T-βMCA sodium induces proliferation and DNA damage in Lgr5+ cells.
In Vivo: T-βMCA sodium (400 mg/kg; i.g.; twice a week; for 6 weeks) can effectively recapitulate the ability of HFD to promote CRC progression.
T-βMCA sodium treatment also significantly increases levels of serum cytokines, including IFN-γ, IL-6, and IL-17.
相關(guān)產(chǎn)品:Chenodeoxycholic acid-d5 | FXR antagonist 1 | Sevelamer | Turofexorate isopropyl | EDP-305 | Ursodeoxycholic acid-13C | Tropifexor | INT-767 | Gly-β-MCA | NDB | PX20606 trans racemate | Tauro-β-muricholic acid-d4 (sodium) | BAR502 | FXR antagonist 2 | DY268 | Obeticholic acid-d5 | NR1H4 activator 1 | (Z)-Guggulsterone | Chenodeoxycholic Acid-d4 | Forskolin | Chenodeoxycholic acid-13C | Obeticholic Acid-d4 | Ursodeoxycholic acid | FXR/TGR5 agonist 1 | HEC96719 | Ursodeoxycholic acid-d5 | Obeticholic acid | Tauro-Obeticholic acid | T0901317
熱門產(chǎn)品線:重組蛋白 | 化合物庫 | 天然產(chǎn)物 | 熒光染料 | PROTAC | 同位素標(biāo)記物 | 寡核苷酸 | 抗體 | 點擊化學(xué)
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種全球僅有化合物庫,我們致力于為全球科研客戶提供前沿的高品質(zhì)小分子活性化合物;
• 50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領(lǐng);
• 產(chǎn)品種類涵蓋各種重組蛋白,多肽,常用試劑盒 ,更有 PROTAC、ADC 等特色產(chǎn)品,廣泛應(yīng)用于新藥研發(fā)、生命科學(xué)等科研項目;
• 提供虛擬篩選,離子通道篩選,代謝組學(xué)分析檢測分析,藥物篩選等專業(yè)技術(shù)服務(wù);
• 設(shè)有專業(yè)的實驗中心和嚴(yán)格的質(zhì)控、驗證體系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質(zhì)檢報告,確保產(chǎn)品的高純度、高品質(zhì);
• 產(chǎn)品的生物活性多經(jīng)各國客戶實驗驗證;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果;
• 專業(yè)團隊跟蹤最新的制藥及生命科學(xué)研究進展,為您提供全球新的活性化合物;
• 與世界各大制藥公司及著名科研機構(gòu)建立了長期的合作。
(空格分隔,最多3個,單個標(biāo)簽最多10個字符)